Product Mix of Novartis

27
Presented By, Group No-01 Animesh Amal (01) Madhura Jagtap (10 Bosco James (15) Shafaatali (18) Bhavika Sachdev (2

description

 

Transcript of Product Mix of Novartis

Page 1: Product Mix of Novartis

Presented By,Group No-01Animesh Amal (01)Madhura Jagtap (10)Bosco James (15)Shafaatali (18)Bhavika Sachdev (23)

Page 2: Product Mix of Novartis

Contents• Mission & Vision• Novartis India• History• People• Top 10 Brands• Current Alliance• Product Mix• Presence• Financial Data• Stock Price• R & D• References

Page 3: Product Mix of Novartis

Mission & Vision

• We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life.

• We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and work in our company.

Page 4: Product Mix of Novartis

Novartis India

Mission Innovative products, Outstanding performance, Ideas and

work.

Vision A better today and tomorrow for patients.

Directors Christopher Snook (Chairman) Ranjit Shahani (Vice Chairman & M.D.)

Page 5: Product Mix of Novartis

History

1996 – The shareholders of Sandoz and Ciba-Geigy approve of the merger.

1997- Novartis announces to acquire crop protection business of Merck & co.

2000 - Novartis seeds are merged with Astrazeneca’s agribusiness operations to form Syngenta.

2001- FDI grants approval of Glivec.2003- Novartis unites it’s generics business

under one single global brand - Sandoz.

Page 6: Product Mix of Novartis

History of Novartis195819701996Present

Page 7: Product Mix of Novartis

People

Full-time associates 2012 total: 127 724

Associates by region, 2012

Page 8: Product Mix of Novartis

Top 10 Brands of Novartis India

Page 9: Product Mix of Novartis

Current Alliance of Novartis

current-alliances.pdf

Page 10: Product Mix of Novartis

Product Mix

Product Mix Width

Pharmaceuticals

Alcon (Eye Care)

Sandoz(Generics)

Over The Counter

Vaccines and Diagnostics

Animal Health

Page 11: Product Mix of Novartis

Pharmaceuticals Autoinflammatory and Autoimmune Disease

Ilaris

Hypertension Amturnide, Diovan, Exforge, Lotrel

Metabolism Cubicin, Tyzeka / Sebivo

Neuroscience Clozaril, Comtan, Extavia, Fanapt

Oncology Exjade, Femara, Tasigna, Gleevec

Ophthalmology Lucentis

Respiratory Foradil, Xolair, TOBI, Arcapta Neohaler

Transplantation Myfortic, Simulect, Neoral, Zortress

Virology/ Anti – invectives Cubicin, Tyzeka / Sebivo

Other Lamisil, Famvir, Riamet, Voltaren, Reclast

Page 12: Product Mix of Novartis

Alcon (Eye Care)

Surgical Infiniti , Constellation, intraocular lenses ,

Ophthalmic Pharmaceuticals Travatan, Moxeza, Pataday, Nevanac

Vision Care Air Optix brand of breathable contact lenses, Dailies, FreshLook colored lenses

Page 13: Product Mix of Novartis

Sandoz(Generics)Anti-coagulant Lovenox®

Anti-infective Augmentin®

Respiratory system Fluimucil®Hypertension Lotrelc®Analgesic Duragesic®Proton pump inhibitor Prevacid®Ulcer & heartburn treatment Prilosec®Cholesterol lowering treatment Zocor®Transplantation Prograf®

Page 14: Product Mix of Novartis

OTCNasal decongestant Otrivin

Paediatric nasal decongestant ProRhinel

Cough suppressant Sinecod

Antihistamine Tavegyl/Tavist

Cough and cold treatment Theraflu

Paediatric cough and cold treatment Triaminic

Cough/ Cold/ Respiratory

Page 15: Product Mix of Novartis

Contd……Fiber supplement Benefiber

Laxative Ex-Lax

Gas reliever Gas-X

Antacid Maalox

Frequent heartburn treatment Prevacid24HR

Digestive Health

Page 16: Product Mix of Novartis

Contd……Pain reliever Excedrin

Anti-inflammatory Voltaren

Calcium supplement CalSource

Skin irritation treatment Fenistil

Antifungal treatment Lamisil

Smoking cessation treatment Nicotinell/Thrive/Habitrol

Systemic antivaricose treatment Venoruton

Pain and Others

Page 17: Product Mix of Novartis

Vaccines and Diagnostics Seasonal flu (influenza) Agrippal, Begrivac, Optaflu, Fluad, Fluvirin

H1N1 Focetria

meningococcal disease Menveo

meningitis Menjugate

stimulating the body's immune response

IXIARO

Tickborne encephalitis Encepur N

Rabies prevention RabAvert

Diphtheria Quinvaxem

poliovirus type 1, 2 and 3 Polioral

Page 18: Product Mix of Novartis

Animal HealthPet Health Atopica, Capstar, Deramaxx , Fortekor,

Interceptor, Milbemax, Milbemax, Prac-tic, Sentinel

Livestock Acatak Duostar, CLiK, Denagard, Fasinex, Vira Shield , ZOLVIX

Bioprotection Agita 10WG, Larvadex, Neporex, Oxyfly, Ratsnip, Spy, Virusnip

Page 19: Product Mix of Novartis

PresenceNorwayPhilippinesPolandPortugalRussiaSlovakiaSpainSwedenSwitzerlandTaiwanTurkeyUnited KingdomUSAVenezuela

FinlandFranceGermanyGreeceHong KongHungaryIndiaIndonesiaItalyJapanKoreaMexico

ArgentinaAustraliaAustriaBangladeshBelgiumBrazilCanadaChileChinaColombiaDenmarkEgyptNorway

Page 20: Product Mix of Novartis

Pharmaceuticals

Alcon Sandoz Vaccines and Diagnostics

Consumer Health

United States 32% 10 392 39% 4 016 32% 2 786 40% 746 17% 652

Europe 32% 10 238 27% 2 710 49% 4 225 35% 658 50% 1 877

Asia/Africa/ Australasia

26% 8 434 23% 2 395 12% 1 057 15% 273 21% 777

Canada and Latin America

10% 3 089 11% 1 104 7% 634 10% 181 12% 429

Total 32 153 10 225 8 702 1 858 3 735

Established Markets

77% 24 778 76% 7 805 74% 6 402 77% 1 434 65% 2 415

Emerging Growth Markets

23% 7 375 24% 2 420 26% 2 300 23% 424 35% 1 320

Total 32 153 10 225 8 702 1 858 3 735

2012 NET SALES BY REGION AND SEGMENT

Page 21: Product Mix of Novartis

2012 NET SALES BY SEGMENT

% USD in millions

Pharmaceuticals 57 32 153

Alcon 18 10 225

Sandoz 15 8 702

Vaccines and Diagnostics 3 1858

Consumer Health 7 3735

Total 56 673

Page 22: Product Mix of Novartis

Pharmaceuticals :- Sales : Rs. 330.5 Cr. (Half year ended September 2012) Growth : 11.8% OTC :- Sales : Rs. 48.2 cr. (Half year ended September 2012) Growth : - 10.07% Animal Health :- Sales : Rs. 47.6 Cr. (Half year ended September 2012) Growth : 16.95%

Sandoz(Generics):- Sales : Rs. 30.6 Cr. (Half year ended September 2012) Growth : 5.15%

Net sales (India)

Page 23: Product Mix of Novartis

Stock Price of NovartisBSE:500672

BSE 590.00 4.05 (+0.69%)VOLUME 42,989 PREV. CLOSE 585.95OPEN PRICE 587.95BID PRICE (QTY.) 590.00 (1,510)OFFER PRICE (QTY.) 0.00 (0)YESTERDAY'S LOW/HIGH 583.10 594.0052 WK LOW/HIGH 574.00 934.20

(as per 14/3/13 data)

Page 24: Product Mix of Novartis

ROLE OF R&D

• Targeting rare and neglected diseases• Ethical research• Responsible R&D

Page 25: Product Mix of Novartis

R&D LOCATIONS OF NOVARTIS

• NIBR PHARMA DEVELOPMENT -EMERYVILLE US -INDIA -LA JOLLA CALIFORNIA US -CHINA - FORT WORTH TX USA -JAPAN -CAMBRIDGE US -EAST HANOVER US

-HORSHAM UK VACCINES AND DIAGNOSTIC -BASEL SWITZERLAND -US -SIENA ITALY -ITALY -SINGAPORE -SHANGHAI CHINA

Page 27: Product Mix of Novartis